Recent advances in G6PD research include the development of small molecule inhibitors targeting the enzyme, which could serve as potential treatments for cancer by disrupting the redox balance in cancer cells. Additionally, structural studies of G6PD have provided insights into its catalytic mechanism, aiding the design of more effective inhibitors.
